Co-Diagnostics, Inc. (CODX)

Co-Diagnostics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-46.9	-37.64	-35.33	-14.24	36.66
Depreciation & Amortization	1.11	1.38	1.23	1.28	0.34
Stock-Based Compensation	2.25	5.43	8.34	7.54	5.51
Other Adjustments	17.57	-1.08	-1.96	5.79	1.47
Change in Receivables	-0.03	0.19	2.54	14.92	-8.74
Changes in Inventories	0.13	0.27	0.41	-3.67	5.71
Changes in Accounts Payable	-3.11	2.16	1.77	-2.48	-0.3
Changes in Income Taxes Payable	-0.71	0.05	-0.52	-2.2	2.64
Changes in Unearned Revenue	-0.03	-0.32	0.36	-0.15	-0.16
Changes in Other Operating Activities	0.59	0.41	1.08	-0.22	-2.05
Operating Cash Flow	-29.14	-29.16	-22.08	6.57	41.08
Operating Cash Flow Growth	-	-	-	-84.01%	45.86%
Capital Expenditures	-0.7	-0.75	-1.37	-1.43	-0.67
Purchases of Investments	-6.59	-40.8	-110.5	-68	-
Proceeds from Sale of Investments	33.67	58.77	127.25	11.26	3.08
Payments for Business Acquisitions	-	-	-	-	1.2
Other Investing Activities	-0.1	-0.14	-	-	0.49
Investing Cash Flow	26.27	17.07	15.39	-58.17	4.1
Issuance of Common Stock	11.81	0.1	-	0.18	0.45
Repurchase of Common Stock	-	-	-1.36	-14.21	-
Net Common Stock Issued (Repurchased)	11.81	0.1	-1.36	-14.03	0.45
Financing Cash Flow	11.81	0.1	-1.36	-14.03	0.45
Net Cash Flow	8.95	-11.98	-8.06	-65.63	45.63
Free Cash Flow	-29.84	-29.9	-23.45	5.14	40.41
Free Cash Flow Growth	-	-	-	-87.28%	47.54%
FCF Margin	-4793.17%	-763.78%	-344.20%	15.02%	41.28%
Free Cash Flow Per Share	-22.43	-29.57	-23.97	4.90	40.54
Levered Free Cash Flow	-49.62	-34.44	-32.36	-23.12	42.17
Unlevered Free Cash Flow	-51.22	-36.95	-36.62	-29.26	42.51

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.